Navigation Links
The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program
Date:10/6/2009

PITTSBURGH, Oct. 6 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, announced that two nationally recognized executives have joined the PLSG as Executives in Residence (EIR).

Joining the PLSG as EIRs are Dave Mawhinney and Stephen A. Bollinger.

Mr. Mawhinney possesses a vast background in marketing, product development, operations and entrepreneurial ventures including four healthcare IT start-ups. In addition to his executive management experience in those start-ups; Premier Health Exchange, Hawk Medical Supply Corp., and IndustryNet Corporation, he worked for the venture capital firm PNC Technology Investors and Bayer Corporation. Mr. Mawhinney holds a Bachelor of Science Degree in Physics from Indiana University of Pennsylvania and a Masters Degree in Business Administration from Carnegie Mellon University.

Mr. Bollinger brings extensive experience with medical device companies where he applied his background in marketing, product management and operations. In addition to his senior management experience with these companies, he also worked for the venture capital firm Highland Capital Partners where he held the position of Executive-in-Residence, helping to build companies and identify investments in the healthcare segment of that firm. Mr. Bollinger holds a Bachelor of Science Degree in Mechanical Engineering from the United States Military Academy and a Masters Degree in Business Administration from Oklahoma City University.

"Our Executive Program has responded to the life sciences community's demand; providing executive talent to help form companies; subject matter experts to guide companies; executives to run companies; and program managers and directors to help companies grow," said John W. Manzetti, PLSG's President and Chief Executive Officer.

Since inception, 30 life sciences experts have participated in the PLSG Executive Program. Seven of those executives remain active in the PLSG Executive Program and twenty remain in western Pennsylvania's life sciences community -- twelve as CEOs and eight as C-Suite and Executive Team members.

"The addition of these two accomplished professionals builds on the credibility of the Executive Program and the investment interest that the PLSG portfolio has received at the national venture capital level," added Jim Jordan, PLSG's Vice President & Chief Investment Officer. "Our national reputation for attracting world-class life sciences talent will help insure the continued growth of the region's economic base and life sciences sector from concept to commercialization.(TM)"

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. For more information, visit www.plsg.com.

SOURCE Pittsburgh Life Sciences Greenhouse


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
2. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
5. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
6. The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
7. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
8. Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp
9. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
10. Pittsburgh Technology Council Announces Technology 50
11. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon ... awards honoring scientists who have made outstanding contributions to analytical chemistry ... Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will feature ... Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ... how to continue to feed a growing nation. At the same time, many of ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... line of medical marijuana products targeting the needs of consumers who are incorporating ... Kindred takes place in Phoenix, Arizona. , As operators of two successful Valley ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... consulting for microscopy and surface analysis, Nanoscience Instruments is now expanding into ... a broad range of contract analysis services for advanced applications. Services will ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):